Global
China's Pharma Industry Resilient in the Face of Slowing Economy
The current economic slowdown notwithstanding, a new survey offers a very positive outlook for the pharma industry in China, with 92 percent of respondents believing their China sales will double over the next five years. Cameron Sharp reports
...Read more |
Research shows that the best pharma reps use iPads to achieve 33% longer calls and improve physician engagement by 50%.
 Read the report to learn how your reps can make the biggest impact with their tablets.
|
Comment
So What's Holding Up a 100-Year-Old Super Bug Killer?
A non-antibiotic bactericidal treatment for humans was first proven effective in 1919. Bacteriophage use continued in the Eastern Bloc after the West switched to antibiotics in the 1940s, and is still in use today in Russia, Poland and Georgia. So, asks Ansis Helmanis, why are bacteriophages for human use not commercially available in the US?
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
Technology
Time for a Wearable Strategy
Analysts are saying that more than 4 million Apple Watches were sold in Q2 2015, grabbing up to 75 percent of the smartwatch market, way ahead of nearest rival Samsung. The unstoppable rise of wearable technology is thanks in particular to health and fitness applications. Peter Houston reports
...Read more |
Pharmaceutical Executive E-Book – Coming October 2015: Changing Contours of Commercialization: Impact of US Health Reform on Patients, Payers and Providers
Key Topics include:
- Phase-in of the 2010 Affordable Care Act: Five stages of pain and plenty
- Pay for Performance and Shared Savings Programs – Implications for Pharma Marketers
- How ACO models are driving physician and provider decision-making
- Primer on policies and financial drivers impacting payer markets – MLR, MSSP, CMS etc.
 Contact your sales rep for more information and to secure your sponsorship. |
Pricing
High Drug Prices: What Would Donald Trump Say?
A recent poll reported that most Americans think drug prices are unreasonably high, but that 76% of Republicans prefer market competition over government regulation to lower prices. Stephen Littlejohn imagines what Donald Trump might say on the matter
...Read more |
No Access, No Business: The rocky road to Market Access Excellence
Live Webinar: Tuesday, 1 September 2015 at 11 am EDT / 4 pm BST / 5 pm CEST
No access = no business!
Market Access needs to be the most important function in your organization. Transforming this function to fulfill that key role is difficult, but possible. Learn in our webcast how to achieve true Excellence in Market Access and be ready for future challenges.
 Register Free |
 |
 // AMAG Pharmaceuticals (Waltham, MA) announced that Joseph Vittiglio has joined the company as Senior Vice President, General Counsel and Secretary.// Achaogen (South San Francisco, CA) announced the appointment of Blake Wise as its Chief Operating Officer, effective October 1, 2015.// GenoSpace (Cambridge, MA) appointed Matthew Fischer as Vice President, Sales & Marketing.// AXIM Biotechnologies (New York, NY) appointed Joe Grace to its Board of Advisors.// |
|
|
